Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools

Authors:
  • OIOn behalf of the Precision Cardio-Oncology Enterprise (P-CORE) Investigators
    On behalf of the Precision Cardio-Oncology Enterprise (P-CORE) Investigators

Abstract
No abstract available